GRFS
NASDAQ
$7.61
Grifols SA (GRFS)
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $10.87 (+42.84%)
Market Cap
$4.91B
PEG Ratio
0.08
P/B Ratio
0.79
Forward P/E
8.40
Price Chart
Valuation
Market Cap$4.91B
P/E10.11
Forward P/E8.40
PEG0.08
P/S0.67
P/B0.79
Profitability
Total Revenue (TTM)$8.60B
Gross Profit (TTM)$3.30B
EBITDA$1.80B
Profit Margin4.3%
Operating Margin14.7%
EPS$0.71
Financial Health
Debt-to-Equity177.2%
Free Cash Flow Yield16.88%
Dividend Yield3.87%
Growth & Risk
EPS 5Y CAGR-10.20%
Revenue 5Y CAGR+5.39%
FCF 5Y CAGR-5.03%
Dividends 5Y CAGR-12.03%
Beta (5Y)0.85
Sharpe Ratio-0.76